Ensysce Biosciences Stock Alpha and Beta Analysis
| ENSCW Stock | USD 0 0 42.50% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Ensysce Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Ensysce Biosciences over a specified time horizon. Remember, high Ensysce Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Ensysce Biosciences' market risk premium analysis include:
Beta (0.54) | Alpha (0.47) | Risk 27.03 | Sharpe Ratio (0.1) | Expected Return (2.58) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Ensysce |
Ensysce Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Ensysce Biosciences market risk premium is the additional return an investor will receive from holding Ensysce Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Ensysce Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Ensysce Biosciences' performance over market.| α | -0.47 | β | -0.54 |
Ensysce Biosciences Fundamentals Vs Peers
Comparing Ensysce Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ensysce Biosciences' direct or indirect competition across all of the common fundamentals between Ensysce Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ensysce Biosciences or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Ensysce Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Ensysce Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ensysce Biosciences to competition |
| Fundamentals | Ensysce Biosciences | Peer Average |
| EBITDA | (27.79 M) | 3.9 B |
| Net Income | (29.15 M) | 570.98 M |
| Total Debt | 4.44 M | 5.32 B |
| Cash Flow From Operations | (8.24 M) | 971.22 M |
| Number Of Employees | 6 | 18.84 K |
| Total Asset | 16.42 M | 29.47 B |
| Z Score | -3.3 | 8.72 |
Ensysce Biosciences Opportunities
Ensysce Biosciences Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Ensysce Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Ensysce or other pink sheets. Alpha measures the amount that position in Ensysce Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ensysce Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ensysce Biosciences' short interest history, or implied volatility extrapolated from Ensysce Biosciences options trading.
Build Portfolio with Ensysce Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Ensysce Pink Sheet Analysis
When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.